FDA Releases Final Guidance on Considerations for the Use of Real-World Data and Real-World Evidence
The Guidance amends the 2021 draft guidance regarding products used under an Emergency Use Authorization and use of patient-level data…
Read More →
Travelers Prop. Cas. Co. of Am. v. H.E. Sutton Forwarding Co., LLC, No. 2:21-CV-719-JES-KCD, 2023 WL 5486746 (M.D. Fla. Aug.…
Read More →
On September 5, 2023, Blue Cross Blue Shield of Illinois (“BCBSIL”) filed a notice of data breach on behalf of…
Read More →
On November 2, 2023, The Hilb Group Operating Company, LLC (“Hilb”) filed a notice of data breach with the Attorney…
Read More →
Hair straightening products have recently been linked to health problems, including uterine cancer. While this is a startling development, it…
Read More →
Life sciences companies face unique exposures and these increase when those companies commence human clinical trials. Based on our recent…
Read More →
…and introducing Sophos X-Ops’ new video channel, which provides viewers (and readers too) with a little something extra…
Read More →
Welcome to this week’s issue of AI: The Washington Report, a joint undertaking of Mintz and its government affairs affiliate,…
Read More →
n October 30, President Biden issued the long-awaited Executive Order on the Safe, Secure, and Trustworthy Development and Use of…
Read More →
On October 30, 2023, President Biden published a landmark Executive Order regarding the use of Artificial Intelligence (“AI”) with an…
Read More →